NCT01942681View on ClinicalTrials.gov

Female Patients With Signs of uRgE and Stress Urinary Incontinence Study of Propiverine Hydrochloride

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Urinary Incontinence
Interventions
DRUG

Propiverine Hydrochloride

Administrate Propiverine Hydrochloride for 12 weeks

Trial Locations (1)

390-8621

Shinshu University Hospital, Matsumoto

All Listed Sponsors
collaborator

Shinshu University Hospital

UNKNOWN

lead

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

OTHER

NCT01942681 - Female Patients With Signs of uRgE and Stress Urinary Incontinence Study of Propiverine Hydrochloride | Biotech Hunter | Biotech Hunter